Inventor
AHN CHANG HO
KR17 patents
⚠️ This page may combine multiple inventors who share the name “AHN CHANG HO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAGNACHIP SEMICONDUCTOR LTD
4 patentsUS9905185B2Feb 27, 2018
Switched column driver of display device
MAGNACHIP SEMICONDUCTOR LTD0 citations50
US9767749B2Sep 19, 2017
Switched column driver of display device
MAGNACHIP SEMICONDUCTOR LTD0 citations50
US9007104B2Apr 14, 2015
Apparatus for output buffering having half-swing rail-to-rail structure
MAGNACHIP SEMICONDUCTOR LTD0 citations50
US9711074B2Jul 18, 2017
Apparatus and method for preventing image display defects in a display device
MAGNACHIP SEMICONDUCTOR LTD0 citations48
REXAHN CORP
3 patentsUS7405214B2Jul 29, 2008
Nucleoside derivatives and therapeutic use thereof
REXAHN CORP14 citations82
US7122527B2Oct 17, 2006
Use of antisense oligonucleotides to inhibit the expression of human Akt-1
REXAHN CORP12 citations79
US7205283B2Apr 17, 2007
Antisense oligonucleotides that inhibit expression of HIF-1
REXAHN CORP9 citations69
REXAHN PHARMACEUTICALS INC
3 patentsUS9713615B2Jul 25, 2017
Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds
REXAHN PHARMACEUTICALS INC0 citations51
US10052321B2Aug 21, 2018
Nanoparticulate compositions and formulations of piperazine compounds
REXAHN PHARMACEUTICALS INC0 citations50
US9744167B2Aug 29, 2017
Nanoparticulate compositions and formulations of piperazine compounds
REXAHN PHARMACEUTICALS INC0 citations48
LEE YOUNG BOK
3 patentsUS9193707B2Nov 24, 2015
Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds
LEE YOUNG BOK0 citations50
US8404698B2Mar 26, 2013
Quinazoline derivatives and therapeutic use thereof
LEE YOUNG BOK1 citations50
US8314123B2Nov 20, 2012
5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof
LEE YOUNG BOK0 citations47